Roowin is a privately owned and agile Contract Research Organisation (CRO), headquartered in Riom (Clermont-Ferrand), France. Specializing in complex chemistry, we provide a comprehensive suite of chemical and analytical services designed to accelerate your drug development journey.

From early drug discovery through process development, we partner with you to advance your small molecule candidates—supporting you all the way to IND/IMPD submission and beyond, including Phase II API licensing or small-scale commercial production (up to ~20 kg).”

With almost 30 thirty years of experience, more than a hundred molecules advanced to the clinic, and a track record of producing the first batches for dozens of startups —some now valued at several billion on the stock market—Roowin demonstrates an exceptionally strong proven record.

Within its custom manufacturing department, Roowin studies all projects of API synthesis under cGMP (current Good Manufacturing Practices).
Roowin can produce batches in a wide range of quantities (from 50 mg up to several dozen kilograms) and support the development of APls from the exploratory stage to advanced clinical phases.

Throughout a cGMP project, Roowin provides complete production-related documentation, satisfying the highest industry standards.
From identification and purchase of raw material, through detailed intermediate analysis and up to final batch release, Roowin minutely tracks every step on the way to the final API.